Scientific Reports · 2024 · 13 citations · 31 references
MedicineMolecular BiologyOncologyCarcinogenesisGene ExpressionMolecular OncologyCancer BiomarkersCancer TranscriptomicsMicrorna BiologyMicrorna-mediated RegulationMolecular Tumor ProfilingNoncoding Rna In CancerMicrorna BiomarkersMicrorna Expression ProfilingMicrorna Function In CancerMicrorna In CancerMicrorna Regulation In CancerMicrorna TherapeuticsMicrorna-mediated OncogenesisStat3 Signaling
Breast cancer (BC) is a leading cause of global female cancer-related deaths, despite treatment advancements. A growing focus on investigating microRNA-based therapeutics and their role in BC progression. A computational analysis was performed to identify the potential miRNA-mRNA network involved in the BC pathogenesis and assist with the treatment strategy. Then, the expression levels of five circulatory miRNAs (miR-200a-3p, miR-124-3p, miR-205-5p, miR-15a-5p, and miR-155-5p) were assessed by using qRT-PCR in 75 BC patients (early-stage: n = 26 and late-stage: n = 49) and 20 healthy controls. The analysis included various (a) stages (early and late) and (b) receptor statuses (ER + ve & HER2 -ve), (HER + ve & ER -ve), and triple-negative (TNBC). In-silico analysis suggested that STAT3 serves as an efficacy biomarker suppressed by miR-124-3p. Additionally, the miR-155-5p showed the ability to activate CTNNB1 which acts as a biomarker for BC progression, to inhibit DNA repair genes (ARID2, and WEE1), and the transcriptional factor gene (TCF4). MiR-205-5p and miR-16 suppressed VEGFA expression, a survival factor for BC. MiR-200a-3p, miR-205-5p, and miR-124-3p showed downregulation in the serum of BC patients compared to controls. The ROC analysis of those miRNAs demonstrated their significant diagnostic accuracy for identifying BC patients. Additionally, miR-155-5p exhibited a significant upregulation in TNBC and can be used as an indicative marker for TNBC. This study holds significant promise for the development of noninvasive miRNA biomarkers with potential clinical applications.
31
Causal analysis approaches in Ingenuity Pathway Analysis
A. Krämer, Jeff Green, Jack Pollard et al. · Bioinformatics · 2013 · 6.1K citations · Full text
Liana Adam, Meng Zhong, Woonyoung Choi et al. · Clinical Cancer Research · 2009 · 408 citations · Full text
MicroRNA expression analysis in triple-negative (ER, PR and Her2/neu) breast cancer
Jelena Radojicic, Apostolos Zaravinos, Thomas Vrekoussis et al. · Cell Cycle · 2011 · 260 citations · Full text
MicroRNAs as Novel Biomarkers for Breast Cancer
Helen Heneghan, Nicola Miller, Aoïfe Lowery et al. · Journal of Oncology · 2009 · 152 citations · Full text